Back

Effect of colchicine on reducing c-reactive protein levels among patients with acute coronary syndrome: a meta-analysis

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Acute Coronary Syndromes ePosters Inflammation ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Godofredo Vistal

Saint Lukes Medical Center Global City, Taguig (Philippines)

205 More presentations in this session

Presentation thumbnail
Optimal timing of intervention in NSTE-ACS without pre-treatment
Doctor I. Almeida (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Antithrombotic strategy in patients with atrial fibrillation and acute coronary syndrome
Doctor I. Almeida (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Drug-eluting balloon catheters in the treatment of left main coronary artery bifurcation lesions: 4-years follow-up
Associate Professor D. Maximkin (Moscow, RU)
Abstract Slides
Presentation thumbnail
Clinical outcomes by angiographic type of spontaneous coronary artery dissection
Doctor R. Mori Junco (Lugo, ES)
Abstract Slides
Presentation thumbnail
Clinical impact of CREDO-kyoto risk score on in-hospital bleeding in patients with acute coronary syndrome
Doctor Y. Minematsu (Saga, JP)
Abstract Slides

Access the full session

Session thumbnail
Acute Coronary Syndromes ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Is there value in prescribing colchicine in coronary artery disease for secondary prevention: a meta-analysis of over 5,000 patients
28 August 2020
thumbnail
Congress Presentation
C-reactive protein in addition to GRACE Score improves risk stratification in acute coronary syndrome
22 May 2023
thumbnail
Congress Presentation
Effect and safety of PCSK9 inhibitor in-hospital use on blood lipid level in the ACS patients: a systematic review and meta-analysis
13 April 2024
thumbnail
Congress Presentation
Relation between serum levels of long acting penicillin and the inflammatory markers: High sensitivity c-reactive protein and interleukin -6 in patients with chronic rheumatic heart disease
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources